These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68 related articles for article (PubMed ID: 10611198)
1. Clinical efficacy of peritoneovenous shunting for the treatment of severe ovarian hyperstimulation syndrome. Koike T; Araki S; Minakami H; Ogawa S; Sayama M; Shibahara H; Sato I Hum Reprod; 2000 Jan; 15(1):113-7. PubMed ID: 10611198 [TBL] [Abstract][Full Text] [Related]
2. Dynamic changes of the immunoglobulins in patients with severe ovarian hyperstimulation syndrome: efficacy of a novel treatment using peritoneo-venous shunt. Takamizawa S; Shibahara H; Taneichi A; Obara H; Fujiwara H; Ogawa S; Koike T; Idei S; Sato I Am J Reprod Immunol; 2002 Jan; 47(1):25-30. PubMed ID: 11883746 [TBL] [Abstract][Full Text] [Related]
3. Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites. Ginès P; Arroyo V; Vargas V; Planas R; Casafont F; Panés J; Hoyos M; Viladomiu L; Rimola A; Morillas R N Engl J Med; 1991 Sep; 325(12):829-35. PubMed ID: 1875966 [TBL] [Abstract][Full Text] [Related]
4. Treatment of ascites in cirrhosis. Diuretics, peritoneovenous shunt, and large-volume paracentesis. Arroyo V; Ginès P; Planas R Gastroenterol Clin North Am; 1992 Mar; 21(1):237-56. PubMed ID: 1568775 [TBL] [Abstract][Full Text] [Related]
5. A new effective method in the treatment of severe ovarian hyperstimulation syndrome. Zhang Q; Xia L; Gao G Iran J Reprod Med; 2012 Nov; 10(6):589-94. PubMed ID: 25246931 [TBL] [Abstract][Full Text] [Related]
6. Treatment of severe ovarian hyperstimulation syndrome by a conservative medical approach. Balasch J; Fábregues F; Arroyo V; Jiménez W; Creus M; Vanrell JA Acta Obstet Gynecol Scand; 1996 Aug; 75(7):662-7. PubMed ID: 8822662 [TBL] [Abstract][Full Text] [Related]
8. [Dual Cycle and Dual Channel Regimen in the Treatment of Severe Ovarian Hyperstimulation Syndrome with Pregnancy]. Cidan LM; Chen L; Zhang D Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 Nov; 46(6):949-52. PubMed ID: 26867335 [TBL] [Abstract][Full Text] [Related]
9. [Intensive care and treatment of severe ovarian hyperstimulation syndrome]. Ma MY; Wen WB; Zhou LX; Yu TO; Fang B Di Yi Jun Yi Da Xue Xue Bao; 2004 Oct; 24(10):1212-4. PubMed ID: 15485803 [TBL] [Abstract][Full Text] [Related]
10. Conservative management of ovarian hyperstimulation syndrome. Morris RS; Miller C; Jacobs L; Miller K J Reprod Med; 1995 Oct; 40(10):711-4. PubMed ID: 8551473 [TBL] [Abstract][Full Text] [Related]
11. The use of intravenous albumin in patients at high risk for severe ovarian hyperstimulation syndrome. Asch RH; Ivery G; Goldsman M; Frederick JL; Stone SC; Balmaceda JP Hum Reprod; 1993 Jul; 8(7):1015-20. PubMed ID: 8408480 [TBL] [Abstract][Full Text] [Related]
12. Intravenous albumin administration for the prevention of severe ovarian hyperstimulation syndrome: a systematic review and metaanalysis. Venetis CA; Kolibianakis EM; Toulis KA; Goulis DG; Papadimas I; Tarlatzis BC Fertil Steril; 2011 Jan; 95(1):188-96, 196.e1-3. PubMed ID: 20579987 [TBL] [Abstract][Full Text] [Related]
13. Pregnancy and neonatal outcomes following luteal GnRH antagonist administration in patients with severe early OHSS. Lainas GT; Kolibianakis EM; Sfontouris IA; Zorzovilis IZ; Petsas GK; Lainas TG; Tarlatzis BC Hum Reprod; 2013 Jul; 28(7):1929-42. PubMed ID: 23624582 [TBL] [Abstract][Full Text] [Related]